Square Pharmaceuticals PLC. (DSE: SQURPHARMA)

DSE: SQURPHARMA Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	55,289	52,013	50,094	48,962	43,364	32,564
Cash & Short-Term Investments	55,289	52,013	50,094	48,962	43,364	32,564
Cash Growth	-2.58%	3.83%	2.31%	12.91%	33.16%	20.59%
Accounts Receivable	3,220	2,551	3,421	2,159	1,636	1,520
Other Receivables	2,057	1,952	2,702	1,236	1,280	1,276
Receivables	5,277	4,503	6,122	3,395	2,916	7,681
Inventory	14,014	12,582	12,227	8,214	7,245	5,687
Prepaid Expenses	82.44	101.51	81.62	57.56	46.17	44.98
Other Current Assets	2,492	2,005	1,962	1,718	1,505	1,407
Total Current Assets	77,154	71,206	70,487	62,348	55,076	47,384
Property, Plant & Equipment	28,659	27,750	26,059	27,183	22,884	20,874
Long-Term Investments	35,080	33,682	25,270	22,227	17,492	13,561
Other Intangible Assets	-	0.05	0.11	-	-	-
Total Assets	140,893	132,637	121,816	111,758	95,452	81,819
Accounts Payable	1,532	1,455	1,002	625.98	666.17	553.79
Accrued Expenses	1,767	1,476	1,327	1,257	1,121	988.27
Current Portion of Long-Term Debt	698.73	614.54	618.61	200	-	-
Current Income Taxes Payable	1,080	912.27	356.1	911.5	572.68	978.04
Other Current Liabilities	1,683	823.65	926.1	666.85	818.87	721.46
Total Current Liabilities	6,760	5,282	4,229	3,662	3,179	3,242
Long-Term Debt	665.45	814.54	1,368	1,714	103.71	-
Long-Term Deferred Tax Liabilities	706.55	619.08	1,022	1,179	1,275	1,213
Total Liabilities	8,132	6,716	6,620	6,555	4,557	4,454
Common Stock	8,865	8,865	8,865	8,865	8,865	8,442
Additional Paid-In Capital	2,035	2,035	2,035	2,035	2,035	2,035
Retained Earnings	121,288	115,196	103,578	93,463	78,855	67,298
Comprehensive Income & Other	568.96	-177.13	717.6	839.61	1,139	-410.88
Total Common Equity	132,757	125,919	115,196	105,203	90,895	77,365
Minority Interest	3.06	2.32	0.71	0.47	0.5	-
Shareholders' Equity	132,760	125,922	115,197	105,203	90,895	77,365
Total Liabilities & Equity	140,893	132,637	121,816	111,758	95,452	81,819
Total Debt	1,364	1,429	1,987	1,914	103.71	-
Net Cash (Debt)	64,088	59,877	52,697	51,395	47,885	35,256
Net Cash Growth	4.12%	13.62%	2.53%	7.33%	35.82%	17.45%
Net Cash Per Share	72.30	67.55	59.45	57.98	54.02	39.77
Filing Date Shares Outstanding	886.45	886.45	886.45	886.45	886.45	886.45
Total Common Shares Outstanding	886.45	886.45	886.45	886.45	886.45	886.45
Working Capital	70,393	65,924	66,258	58,686	51,898	44,143
Book Value Per Share	149.76	142.05	129.95	118.68	102.54	87.27
Tangible Book Value	132,757	125,919	115,196	105,203	90,895	77,365
Tangible Book Value Per Share	149.76	142.05	129.95	118.68	102.54	87.27
Land	-	8,486	6,632	6,446	6,136	5,711
Buildings	-	11,897	11,716	10,317	9,756	9,744
Machinery	-	30,103	29,322	26,788	25,510	24,061
Construction In Progress	4,070	1,774	1,083	6,388	2,460	724.65

Source: S&P Capital IQ. Standard template. Financial Sources.